Literature DB >> 23656653

Cinacalcet for cardiovascular disease in patients undergoing dialysis.

Glenn M Chertow, Patrick S Parfrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23656653     DOI： 10.1056/NEJMc1301247

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Authors:  Sharon M Moe; Safa Abdalla; Glenn M Chertow; Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Bastian Dehmel; William G Goodman; Tilman B Drüeke
Journal:  J Am Soc Nephrol       Date:  2014-12-11       Impact factor: 10.121

2.  A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification.

Authors:  Linda Awdishu; Teri Moore; Michelle Morrison; Christy Turner; Danuta Trzebinska
Journal:  Pharmacy (Basel)       Date:  2019-07-03

3.  Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease.

Authors:  Fizza Abbas; Daniel W Coyne
Journal:  Kidney Res Clin Pract       Date:  2019-06-30

4.  Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study.

Authors:  Jacques Rottembourg; Pablo Ureña-Torres; Daniel Toledano; Victor Gueutin; Abdelaziz Hamani; Olivier Coldefy; Hedia Hebibi; Thomas Guincestre; Corinne Emery
Journal:  Clin Kidney J       Date:  2019-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.